← Back to Clinical Trials
Recruiting NCT05515341

A DirEct to PatieNt Study in Chronic Pain

Trial Parameters

Condition Chronic Pain
Sponsor Boston Scientific Corporation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50,000
Sex ALL
Min Age 22 Years
Max Age N/A
Start Date 2023-01-10
Completion 2029-12
Interventions
Commercially Approved Interventional Medical Device/Therapy for Chronic Pain

Brief Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Eligibility Criteria

Key Inclusion Criteria: * Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting * Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening * Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English Key Exclusion Criteria: * Requires a legal representative to sign the ICF ascertained from self-reporting

Related Trials